Thromb Haemost 1988; 59(03): 464-467
DOI: 10.1055/s-0038-1647516
Original Article
Schattauer GmbH Stuttgart

Standardization of Protein C in Plasma: Establishment of an International Standard

A R Hubbard
The National Institute for Biological Standards and Control, London, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 22. Dezember 1987

Accepted 11. Februar 1988

Publikationsdatum:
29. Juni 2018 (online)

Summary

An international collaborative study, involving 18 laboratories, was carried out to establish an international standard for protein C in plasma. The proposed standard, which consisted of a freeze-dried ampouled plasma preparation coded 86/622, was assayed against fresh normal plasma and the participants’ local standards. Protein C activity assays were placed in four groups, depending on the method of activation and detection of protein C. The combined potencies (units per ampoule) for the proposed international standard were: thrombin activation/clottirg assays, 0.86; thrombin activation/chromogenic assays, 0.81; snake venom activation/clotting assays, 0.81 and snake venom activation/chromogenic assays, 0.82. Measurement of protein C antigen gave potency estimates of 0.81 and 0.82 units per ampoule for the Laurell electroimmunoassay and ELISA techniques, respectively. The good agreement in potency estimates between the different methods indicates that the overall combined figure (226 assays) for the international standard of 0.82 international units per ampoule should serve for all methods. Accelerated degradation studies have indicated that the standard should be suitably stable when stored at −20° C.

The freeze-dried plasma 86/622 has been established by the WHO Expert Committee on Biological Standardization as the 1st International Standard for Protein C in Plasma, with an assigned unitage of 0.82 international units per ampoule.

 
  • References

  • 1 Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-5831
  • 2 Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
  • 3 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
  • 4 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
  • 5 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
  • 6 Broekmans AW. Hereditary protein C deficiency. Haemostasis 1985; 15: 233-240
  • 7 Bertina RM, Broekmans AW, Krommenhoek-van EsC, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemostas 1984; 51: 1-5
  • 8 Campbell PJ. International biological standards and reference preparations. II: Procedures used for the production of biological standards and reference preparations. J Biol Stand 1974; 2: 259-267
  • 9 Francis RB, Patch MJ. A functional assay for protein C in human plasma. Thromb Res 1983; 32: 605-613
  • 10 Sala N, Owen WG, Collén D. A functional assay of protein C in human plasma. Blood 1984; 63: 671-675
  • 11 Lobermann H, Kolde H-J, Deubel R, Peter R, Tourte E, Becker U. Determination of protein C in plasma. Behring Inst Mitt 1986; 79: 112-120
  • 12 Vinazzer H, Pangraz U. Protein C: comparison of different assays in normal and abnormal plasma samples. Thromb Res 1987; 46: 1-8
  • 13 Martinoli JL, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986; 43: 253-264
  • 14 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
  • 15 Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63
  • 16 Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu MJ. A new method for estimation of protein C by ELISA. Thromb Res 1984; 36: 579-589
  • 17 Amiral J, Adalbert B, Adam M. Application of enzyme immunoassays to coagulation testing. Clin Chem 1984; 30: 1512-1516
  • 18 Finney DJ. Statistical Method in Biological Assay. Griffin & Co Ltd; London: 1978
  • 19 Kirkwood TB L, Tydeman MS. Design and analysis of accelerated degradation tests for the stability of biological standards. II: A flexible computer program for data analysis. J Biol Stand 1984; 12: 207-214
  • 20 Bertina RM. An international collaborative study on the performance of protein C antigen assays. Thromb Haemostas 1987; 57: 112-117
  • 21 Mannucci RM, Boyer C, Tripodi A, Viganò-D’Angelo S, Wolf M, Valsecchi C, D’Angelo A, Meyer D, Larrieu MJ. Multicenter comparison of five functional and two immunological assays for proteinC. Thromb Haemostas 1987; 57: 44-48